LICENSE AND SUPPLY TRANSFER AGREEMENTLicense and Supply Transfer Agreement • March 10th, 2016 • Galena Biopharma, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 10th, 2016 Company IndustryTHIS LICENSE AND SUPPLY TRANSFER AGREEMENT (this “Transfer Agreement”) is entered into as of December 16, 2015 (the “Effective Date”) by and between MonoSol Rx, LLC (“MonoSol”) and Galena Biopharma, Inc. (“Galena”).
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 10th, 2016 • Galena Biopharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 10th, 2016 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of December 17, 2015, is made by and between GALENA BIOPHARMA, INC., a Delaware corporation (“Seller”), and MIDATECH PHARMA PLC, a public limited company organized under the laws of England and Wales with registered number 09216368 (“Purchaser”). Seller and Purchaser are sometimes individually referred to herein as a “Party” and are sometimes collectively referred to herein as the “Parties”. Capitalized terms not otherwise defined in the text of this Agreement shall have the meanings set forth in Article I of this Agreement.
Amendment to Offer Letter between Galena Biopharma, Inc. and Thomas J. KnappOffer Letter Amendment • March 10th, 2016 • Galena Biopharma, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 10th, 2016 Company IndustryThis amendment (“Amendment”) to the Offer Letter dated June 23, 2015 between Galena Biopharma, Inc. and Thomas J. Knapp (“Offer Letter”) is made this December 31, 2015 and amends the Offer Letter with the following provisions:
ASSET PURCHASE AGREEMENT by and between GALENA BIOPHARMA, INC. and SENTYNL THERAPEUTICS INC. November 19, 2015Asset Purchase Agreement • March 10th, 2016 • Galena Biopharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 10th, 2016 Company Industry Jurisdiction
SEPARATION AGREEMENT AND RELEASESSeparation Agreement • March 10th, 2016 • Galena Biopharma, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 10th, 2016 Company IndustryThis Separation Agreement and Releases ("Separation Agreement") is made and entered into as of the 16th day of December, 2015, by and between Ryan Dunlap (hereinafter "Executive") and Galena Biopharma, Inc. ("GALENA"), a corporation organized under the laws of the State of Delaware, and its affiliates (hereinafter collectively referred to as the "Company").